Medical Hypotheses
Volume 56, Issue 6 , Pages 644-647 , June 2001

Crosstalk and considerations in endocrine disruptor research

References 

    REFERENCES
  1. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) Final Report, At: http://www.epa.gov/scipoly/oscpendo/history/finalrpt.htm. August 1998
  2. Rutanen EM. Insulin-like growth factors in endometrial function. Gynecol Endocrinol. 1998;12:399–406
  3. Shiraga M, Takahashi S, Miyake T, Takeuchi S, Fukamachi H. Insulin-like growth factor-I stimulates proliferation of mouse uterine epithelial cells in primary culture. Proc Soc Exp Biol Med. 1997;215:412–417
  4. Rajkumar K, Dheen T, Krsek M, Murphy LJ. Impaired estrogen action in the uterus of insulin-like growth factor binding protein-1 transgenic mice. Endocrinology. 1996;137:1258–1264
  5. Kuhara A, Tsuji M, Tsujimura T, Sugihara A, Yamada N, Terada N. Comparison of sensitivities of uterine cells in their proliferation responding to epidermal growth factor and estrogen between neonatal and postneonatal mice. In Vivo. 1999;13:487–491
  6. Curtis SW, Washburn T, Sewall C. Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc Natl Acad Sci USA. 1996;93:12626–12630
  7. Gray K, Bullock B, Dickson R. Potentiation of diethylstilbestrol-induced alterations in the female mouse reproductive tract by transforming growth factor-alpha transgene expression. Mol Carcinog. 1996;17:163–173
  8. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect. 1995;103 Suppl:113–122
  9. Figueroa JA, Sharma J, Jackson JG, McDermott MJ, Hilsenbeck SG, Yee D. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells. J Cell Physiol. 1993;157:229–236
  10. Guvakova MA, Surmacz E. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp Cell Res. 1997;231:149–162
  11. Wight M. Insulin-like growth factor (IGF-I) in bovine sera. Art to Science. 2000;19:1–3
  12. Duda RB, Zhong Y, Navas V, Li MZ, Toy BR, Alavarez JG. American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. J Surg Oncol. 1999;72:230–239
  13. Ignar-Trowbridge DM, Pimentel M, Teng CT, Korach KS, McLachlan JA. Cross-talk between peptide growth factor and estrogen receptor signaling systems. Environ Health Perspect. 1995;103 Suppl:35–38
  14. Picard D, Bunone G, Liu JW, Donze O. Steroid-independent activation of steroid receptors in mammalian and yeast cells and in breast cancer. Biochem Soc Trans. 1997;25:597–602
  15. Rana S, Bisht D, Chakraborti PK. Synergistic activation of yeast-expressed rat androgen receptor by modulators of protein kinase-A. J Mol Biol. 1999;286:669–681
  16. Mahe Y, Lemoine Y, Kuchler K. The ATP binding cassette transporters Pdr5 and Snq2 of Saccharomyces cerevisiae can mediate transport of steroids in vivo. J Biol Chem. 1996;271:25167–25172
  17. Hirohashi T, Suzuki H, Chu XY, Tamai I, Tsuji A, Sugiyama Y. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J Pharmacol Exp Ther. 2000;292:265–270
  18. Cha SH, Sekine T, Kusuhara. H. Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem. 2000;275:4507–4512
  19. Kamei Y, Xu L, Heinzel T. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 1996;85:403–414
  20. Gee AC, Carlson KE, Martini PG, Katzenellenbogen BS, Katzenellenbogen JA20. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Mol Endocrinol. 1999;13:1912–1923
  21. Yeh S, Miyamoto H, Shima H, Chang C. From estrogen to androgen receptor: a new pathway for sex hormones in prostate. Proc Natl Acad Sci USA. 1998;95:5527–5532
  22. Takimoto GS, Graham JD, Jackson TA. Tamoxifen resistant breast cancer: coregulators determine the direction of transcription by antagonist-occupied steroid receptors. J Steroid Biochem Mol Biol. 1999;69:45–50

PII: S0306-9877(00)91249-0

doi: 10.1054/mehy.2000.1249

Medical Hypotheses
Volume 56, Issue 6 , Pages 644-647 , June 2001

Article Tools